Handelsbanken Fonder’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Handelsbanken Fonder’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-153,000	Closed	-$3.2M	–	178
2016 Q3	$3.2M	Hold	153,000	–	–	0.09%	134
2016 Q2	$1.65M	Buy	153,000 +20,000	+15%	+$171K	0.07%	116
2016 Q1	$882K	Buy	133,000 +95,000	+250%	+$864K	0.04%	132
2015 Q4	$688K	Buy	+38,000	New	+$523K	0.01%	580

Handelsbanken Fonder's VTAE Position: Q4 2016 in Review

Handelsbanken Fonder sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 153,000 shares — an estimated $3.2M sold.

Handelsbanken Fonder first reported a position in VTAE in Q4 2015 and held it in 4 quarters. The position peaked at $3.2M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Handelsbanken Fonder reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Handelsbanken Fonder sold 153,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $3.2M.
Handelsbanken Fonder first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2015 and held it in 4 quarters.
Handelsbanken Fonder's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $3.2M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Handelsbanken Fonder's 13F filing for Q4 2016, filed 8 Feb 2017.